Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ropivacaine (LEA-103 HCl) is a local anaesthetic drug belonging to the amino amide group.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
10 mg | 在庫あり | ¥ 9,500 | |||
25 mg | 在庫あり | ¥ 13,500 | |||
50 mg | 在庫あり | ¥ 17,000 | |||
100 mg | 在庫あり | ¥ 22,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 10,500 |
説明 | Ropivacaine (LEA-103 HCl) is a local anaesthetic drug belonging to the amino amide group. |
ターゲット&IC50 | TREK1 (COS-7 cell membrane):402.7 μM (IC50) |
別名 | LEA-103 HCl |
分子量 | 274.4 |
分子式 | C17H26N2O |
CAS No. | 84057-95-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 60 mg/mL (218.65 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ropivacaine 84057-95-4 Membrane transporter/Ion channel Sodium Channel Potassium Channel Inhibitor vasoconstrictive Na+ channels LEA-103 HCl hypertension K(2P) Na channels conduction anaesthetic KcsA pain neuronal inhibit neuropathic TREK-1 channel potassium inhibitor